|
|
Clinical study of Xuanji acupuncture method on attenuation effects of Platinum chemotherapy regimen in the treatment of malignant tumor |
LIAO Guiya1,2 LONG Shunqin1,2 DENG Hong1,2 LI Qiuping1,2 HUANG Jinpeng1,2 GAN Ziyan1,2 BI Jiayi1,2 LIU Yu1 |
1.The Second Clinical College, Guangzhou University of Chinese Medicine, Guangdong Province, Guangzhou 510120, China;
2.Department of Oncology, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangdong Province, Guangzhou 510370, China |
|
|
Abstract Objective To study the clinical effect of Xuanji acupuncture method on attenuation effects of Platinum chemotherapy regimen in the treatment of malignant tumor. Methods Fifty-nine patients with malignant tumor treated in Guangdong Provincial Hospital of Traditional Chinese Medicine from July to December 2017 were selected and randomly divided into observation group (29 cases) and control group (30 cases) according to the random number table method. Both groups were treated with Platinum chemotherapy regimen routinely for 2 courses, while the observation group was treated with Xuanji acupuncture during chemotherapy for 10 days. The cellular immune function, quality of life, bone marrow suppression conditions and digestive tract reactions before and after treatment between the two groups were compared. Results After treatment, the levels of CD3+, CD4+, CD8+ and CD4+/CD8+ in the observation group were significantly higher than those before treatment; the levels of CD3+ and CD4+ in the control group were significantly higher than those before treatment (all P < 0.05). After treatment, the levels of CD3+, CD4+, CD8+ and CD4+/CD8+ in the observation group were significantly higher than those of the control group (P < 0.05). In European organization for research and treatment of cancer (EORTC) QLQ-C30, the score of total health in the observation group was significantly higher than that of the control group, while the scores of nausea, vomiting, pain and appetite were significantly lower than those of the control group (all P < 0.05). The incidence of bone marrow suppression and digestive tract reaction in the observation group were significantly lower than those in the control group (all P < 0.05). Conclusion Xuanji acupuncture method combined with Platinum chemotherapy regimen can reduce toxicity function of patients with malignant tumor, and it can improve the immune function and quality of life, which may deserve for clinical promotion.
|
|
|
|
|
[1] 张定清.吉西他滨联合铂类化疗方案治疗晚期恶性肿瘤的临床观察[J].中国癌症防治杂志,2015,7(1):49-51.
[2] 高传柱,王天帅,陈佳,等.铂类抗肿瘤药物作用机制研究进展[J].昆明理工大学学报:自然科学版,2014,39(4):83-92.
[3] 左常波.斡旋针法治疗慢性胃炎(脾虚气滞型胃痛)临床研究[J].新中医,2015,47(7):231-233.
[4] 陈飞,程祺,杨雅雯.托烷司琼针、甲氧氯普胺针独用及合用对肿瘤化疗恶心、呕吐的预防效果评价[J].中国医药科学,2015,5(24):48-50.
[5] 中华人民共和国卫生部医政司.中国常见恶性肿瘤诊治规范[M].北京:北京医科大学中国协和医大学联合出版社,1991.
[6] 姜文奇.实用肿瘤内科处方用药手册[M].2版.广州:广东科技出版社,2009:105-136.
[7] 万崇华.生命质量测定与评价方法[M].昆明:云南大学出版社,1999:224-227.
[8] 王岩,朱琳,陈鹏.肿瘤患者生命质量测定量表EORTC QLQ-C30维文版评价[J].中国卫生统计,2015,32(3):512-513.
[9] 万崇华,罗家洪,杨铮,等.癌症患者生命质量测定与应用[M].北京:科学出版社,2007:3-4.
[10] 蒋玥,朱璞玉,苏广,等.中医药防治恶性肿瘤化疗毒副作用的治则探讨[J].新中医,2013,45(6):186-187.
[11] 陈万青,孙可欣,郑荣寿,等.2014年中国分地区恶性肿瘤发病和死亡分析[J].中国肿瘤,2018,27(1):1-14.
[12] 张培,吕蒙莹,刘劝,等.中药对铂类抗肿瘤药物的减毒增效作用研究进展[J].药学进展,2013,37(5):207-214.
[13] 叶真龙,金华君,钱其军.CIK细胞联合治疗恶性肿瘤的最新研究进展[J].解放军医药杂志,2015,27(1):25-30.
[14] 董文杰,郑东海,郑伟鸿,等.郑伟达教授治疗恶性肿瘤学术思想[J].世界中医药,2017,12(7):1612-1615.
[15] 郑颖娟,郝少军,张正臣,等.益复康口服液对恶性肿瘤化疗减毒增效的临床应用研究[J].中国现代药物应用,2013,7(15):149-150.
[16] 周树珊,杨敏,张奕珍,等.人参多糖注射液联合放化疗用于恶性肿瘤的系统评价[J].中国药房,2016,27(3):348-350.
[17] 田叶红,黄金昶.针灸治疗恶性肿瘤的最新临床运用进展[J].针灸临床杂志,2014,30(10):82-85.
[18] 王存德,龚泉,张利娟,等.恶性肿瘤姑息治疗的进展[J].中国肿瘤,2012,21(3):206-210.
[19] 莫婷,田欢,岳双冰,等.穴位艾灸治疗肿瘤化疗所致白细胞减少临床观察[J].世界中医药,2016,11(10):2120-2122.
[20] 钟琼,曾治民,吴仁瑞,等.DC-CIK用于恶性肿瘤中的效果及对放射性肠炎的预防作用观察[J].中国现代医生,2016,54(11):53-55.
[21] 廖天华,蔡凯,黄常江,等.中医药治疗恶性肿瘤放化疗常见不良反应的概况[J].云南中医中药杂志,2013,34(7):71-72.
[22] 梁健,常英,郭素敏,等.针灸快速治疗化疗所致腹胀便秘疗效观察[J].临床荟萃,2013,28(8):895-896.
[23] 芦殿荣,芦殿香,何生奇,等.穴位刺激防治含顺铂方案化疗患者消化道副反应的临床研究进展[J].针灸临床杂志,2012,28(10):66-70.
[24] Lee I,Garland SN,DeMichele A,et al. A cross-sectional survey of pain catastrophising and acupuncture use among breast cancer survivors [J]. Acupunct Med,2017,35(1):38-43. |
|
|
|